Examining Issues Related to Competition in the Pharmaceutical Marketplace

Examining Issues Related to Competition in the Pharmaceutical Marketplace PDF Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
Publisher:
ISBN:
Category : Competition
Languages : en
Pages : 150

Get Book

Book Description

Examining Issues Related to Competition in the Pharmaceutical Marketplace

Examining Issues Related to Competition in the Pharmaceutical Marketplace PDF Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
Publisher:
ISBN:
Category : Competition
Languages : en
Pages : 150

Get Book

Book Description


Examining Issues Related to Competition in the Pharmaceutical Market Place: a Review of the FTC Report, Generic Drug Entry Prior to Patent Expiration

Examining Issues Related to Competition in the Pharmaceutical Market Place: a Review of the FTC Report, Generic Drug Entry Prior to Patent Expiration PDF Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
Publisher:
ISBN: 9780756742195
Category : Competition
Languages : en
Pages : 142

Get Book

Book Description
Hearing on whether innovator drug companies may be using questionable tactics to delay the entry of generic competitors. Witnesses: Mark A. Barondess; Lester M. Crawford, Acting Commr., & Daniel D. Troy, Chief Counsel, Food & Drug Admin. (FDA); Gregory J. Glover, Ropes & Tray, on behalf of PhRMA; Kathleen D. Jaeger, Pres. & CEO, Generic Pharmaceutical Assoc.; Sharon Levine, Assoc. Exec. Dir., the Permanente Medical Group, on behalf of RxHealthValue; & Timothy J. Muris, Chmn., Fed. Trade Comm. (FTC).

Generic drug entry prior to patent expiration an FTC study

Generic drug entry prior to patent expiration an FTC study PDF Author:
Publisher: DIANE Publishing
ISBN: 1428951938
Category :
Languages : en
Pages : 129

Get Book

Book Description


Generic Drug Entry Prior to Patent Expiration

Generic Drug Entry Prior to Patent Expiration PDF Author: United States. Federal Trade Commission
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages :

Get Book

Book Description
In April 2001, the Commission began an industry-wide study focused on certain aspects of generic drug competition under the Hatch-Waxman Amendments. The Amendments provide certain methods by which generic drug manufacturers can obtain approval to market a generic version of a brand-name product. The study's purpose was to provide a more complete picture of how generic drug competition has developed under one method the Amendments established: generic entry prior to expiration of the brand-name company's patents on the relevant drug product.

Examining Issues Related to Competition in the Pharmaceutical Marketplace

Examining Issues Related to Competition in the Pharmaceutical Marketplace PDF Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
Publisher:
ISBN:
Category : Competition
Languages : en
Pages : 152

Get Book

Book Description


Generic Drug Entry Prior to Patient Expiration

Generic Drug Entry Prior to Patient Expiration PDF Author: United States. Federal Trade Commission
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 136

Get Book

Book Description


Generic Drug Entry Prior to Patent Expiration

Generic Drug Entry Prior to Patent Expiration PDF Author: United States. Federal Trade Commission
Publisher: William s Hein & Company
ISBN: 9781575887456
Category : Law
Languages : en
Pages : 113

Get Book

Book Description
"In April 2001, the Commission began an industry-wide study focused on certain aspects of generic drug competition under the Hatch-Waxman Amendments. The Amendments provide certain methods by which generic drug manufacturers can obtain approval to market a generic version of a brand-name product. The study's purpose was to provide a more complete picture of how generic drug competition has developed under one method the Amendments established: generic entry prior to expiration of the brand-name company's patents on the relevant drug product. This report sets forth the results of the study. The study was prompted, in part, by the Commission's enforcement actions against alleged anticompetitive agreements that relied on certain Hatch-Waxman provisions. The study was designed to determine whether such agreements are isolated instances or more typical, and whether particular provisions of the Hatch-Waxman Amendments are susceptible to strategies to delay or deter consumer access to low-cost generic alternatives to brand-name drug products." -- from the Introduction, p. 1.

Legislative and Regulatory Responses to the FTC Study on Barriers to Entry in the Pharmaceutical Marketplace

Legislative and Regulatory Responses to the FTC Study on Barriers to Entry in the Pharmaceutical Marketplace PDF Author: United States. Congress. Senate. Committee on the Judiciary
Publisher:
ISBN:
Category : Competition
Languages : en
Pages : 120

Get Book

Book Description


The Pharmaceutical Industry

The Pharmaceutical Industry PDF Author: Roy Levy
Publisher: DIANE Publishing
ISBN: 1428953639
Category : Antitrust law
Languages : en
Pages : 226

Get Book

Book Description


Report on the Activity of the Committee on Energy and Commerce for the ... Congress

Report on the Activity of the Committee on Energy and Commerce for the ... Congress PDF Author: United States. Congress. House. Committee on Energy and Commerce
Publisher:
ISBN:
Category : Energy policy
Languages : en
Pages : 318

Get Book

Book Description